DSCAM and breast carcinoma: Further pioneering studies in the context of breast cancer reported DSCAM-AS1 as the most abundant estrogen receptor α (ERα)-induced lncRNA in MCF-7 breast cancer cells and to be the main distinguishing feature of the luminal subtype of breast cancer [12,13].